Patient Decision Aid for the Treatment of Lentigo Maligna

The Decision Aid for Lentigo Maligna was developed by members of the American Society for Dermatologic Surgery with iterative feedback from patients. It contains evidence-based information regarding LM and various treatment modalities, including surgery, imiquimod 5%, radiation, as well as active surveillance. Treatment-specific information includes treatment efficacy, advantages and adverse effects, expected follow up, and estimated associated costs. The “things I might consider in my decision” section of the decision aid contains questions regarding lifestyle, comorbidities, social factors, and disease-related concerns.

由美国皮肤外科协会成员开发，该 Lentigo Maligna 决策辅助工具经过患者迭代的反馈优化。其中包含关于 Lentigo Maligna 及其各种治疗方式（包括手术、咪喹莫特 5%、放射治疗以及积极监测）的证据基础信息。针对特定治疗的信息包括治疗效果、优点与副作用、预期的随访以及估算的相关成本。决策辅助工具中‘我在决策时可能考虑的因素’部分，包含有关生活方式、合并症、社会因素以及疾病相关担忧的问题。